MEDISENSE, INC. – Trademark Portfolio

Entity Type: 03

MEDISENSE, INC. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. The owner is based in WALTHAM, MA.

266 SECOND AVENUE

WALTHAM, MA 02154

12 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MEDISENSE, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (9 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does MEDISENSE, INC. have?

MEDISENSE, INC. has 12 U.S. trademarks filed with the USPTO.

What trademark classes does MEDISENSE, INC. file in?

MEDISENSE, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What is MEDISENSE, INC.'s trademark registration success rate?

MEDISENSE, INC. has a 0% trademark registration rate, with 0 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.